3 and 4-year M6-C data is out — what spine surgeons should know

Orthofix has released three- and four-year preliminary outcomes from its M6-C artificial cervical disc single-level clinical trial.

Advertisement

What you should know:

1. Patients treated with M6-C “continue to have statistically significant benefits at three and four years” compared to anterior cervical discectomy and fusion patients, Frank Phillips, MD, an investigator in the study, said in a May 11 news release. “This is important as it demonstrates the positive results originally reported in the study have been maintained through four years.”

2. At three years, M6-C patients had a mean Neck Disability Index score of 10.9, compared to 17.2 in the ACDF group.

3. The mean Neck Disability Index for M6-C patients at four years was 10.3, compared to 19.2 for the ACDF cohort.

4. A greater percentage of M6-C disc patients experienced an improvement in Neck Disability Index scores at three and four years compared to the ACDF group. Four-year results were significantly better for the M6-C group.

5. One removal was reported in the M6-C group within the first four years post-surgery, compared to three in the ACDF group.

6. Five-year data is being collected.

Click here for more details on the study.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.